numares and Bruker Sign Agreement to Enable Advanced Metabolomics-based Clinical Diagnostics

numares and Bruker Sign Agreement to Enable Advanced Metabolomics-based Clinical Diagnostics
numares AG and analytical instrumentation and solution provider
Bruker Corporation have signed an agreement to collaborate to bring new diagnostics tests utilizing NMR to the laboratory market for unmet medical needs. The tests are based on the automated measurement of metabolites using a strong magnet field, and artificial intelligence. The platform is marketed under the
numares brand
AXINON
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210121005438/en/
numare's AI-driven, NMR-based diagnostic platform AXINON is easy to operate by laboratory technicians. (Photo: Business Wire)

Related Keywords

Germany ,Winton Gibbons ,Volker Pfahlert ,Christiane Proll ,Iris Mangelschots ,Group Corp ,Bruker Corporation ,Magnetic Group Signaling ,Business Wire ,Mayo Clinic ,Bruker Biospin ,Group Signaling ,Numares ,Bruker ,Sign ,Agreement ,Enable ,Advanced ,Metabolomics ,Based ,Clinical ,Diagnostics ,ஜெர்மனி ,விண்டன் கிப்பன்கள் ,குழு கார்ப் ,ப்ரூக்கர் நிறுவனம் ,காந்த குழு சமிக்ஞை ,வணிக கம்பி ,மயோ சிகிச்சையகம் ,ப்ரூக்கர் பயோஸ்பின் ,குழு சமிக்ஞை ,ப்ரூக்கர் ,அடையாளம் ,இயக்கு ,அடிப்படையிலானது ,மருத்துவ ,பரிசோதனை ,